Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis

Xinjie Liu1, Qizheng Han, Ruopeng Sun

  • 1Department of Pediatrics, Qilu Hospital, Shandong University, No. 107 Wen Hua Xi Road, Jinan 250012, China. liuxinjie2005@sina.com

Brain Research
|April 1, 2008
PubMed

Insights

Matrix metalloproteinases (MMPs) are implicated in bacterial meningitis. This study found dexamethasone, when used with antibiotics, down-regulated MMP-9 expression, suggesting a beneficial therapeutic effect in pneumococcal meningitis.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • Matrix metalloproteinases (MMPs) play a role in bacterial meningitis pathophysiology, facilitating leukocyte extravasation and brain edema.
  • Dexamethasone shows promise as an adjunctive therapy in meningitis, but its specific role in pneumococcal meningitis and its effect on MMPs remain unclear.
  • The impact of antibiotics on MMPs during bacterial meningitis has not been previously evaluated.

Purpose of the Study:

  • To investigate the induction and expression of MMPs, specifically MMP-9 and MMP-2, in experimental pneumococcal meningitis.
  • To examine the regulatory effects of dexamethasone and antibiotics on MMPs during the treatment of pneumococcal meningitis.

Main Methods:

  • Experimental pneumococcal meningitis was induced in rats.
  • Expression of MMP-9 and MMP-2 mRNA in brain tissue and their activity in cerebrospinal fluid (CSF) were measured.
  • Rats were treated with antibiotics alone or in combination with dexamethasone.

Main Results:

  • MMP-9 mRNA expression was significantly upregulated in the brains of rats with pneumococcal meningitis.
  • Antibiotic treatment alone led to a dose-dependent upregulation of MMP-9 expression.
  • Combined treatment with antibiotics and dexamethasone significantly downregulated MMP-9 expression and activity, unlike antibiotic treatment alone.

Conclusions:

  • Antibiotic therapy may increase MMP-9 expression in pneumococcal meningitis.
  • Dexamethasone, as an adjunctive therapy with antibiotics, appears to inhibit MMP-9 expression and activity.
  • Dexamethasone may exert beneficial effects in bacterial meningitis by downregulating MMP-9.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...